1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL HYALURONIC ACID MARKET BY APPLICATION
5.1. Introduction
5.2. Tissue Engineering
5.3. Osteoarthritis Treatment
5.4. Dermal Filler
5.5. Others
6. GLOBAL HYALURONIC ACID MARKET BY END-USERS
6.1. Introduction
6.2. Pharmaceutical Industry
6.3. Cosmetic Surgery Centers
6.4. Dermatology Clinics
6.5. Others
7. GLOBAL HYALURONIC ACID MARKET BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. USA
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. United Kingdom
7.4.4. Spain
7.4.5. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. India
7.6.3. Japan
7.6.4. South Korea
7.6.5. Indonesia
7.6.6. Thailand
7.6.7. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Allergan (AbbVie Inc.)
9.2. Sanofi
9.3. Seikagaku Corporation
9.4. Contipro a.s.
9.5. BioScience GmbH
9.6. Kewpie Corporation
9.7. Bohus BioTech AB
9.8. Humedix.Co.Ltd
9.9. Anika Therapeutics, Inc.
9.10. Laboratoires Vivacy, S.A.S.
9.11. Cosmedica Skincare
9.12. Wellona Pharma
9.13. Plamed Green Science Group
9.14. Revitajal (Beauty Aesthetic Finland Oy)
9.15. Altergon Italy Srl
10. APPENDIX
10.1. Currency
10.2. Assumptions
10.3. Base and Forecast Years Timeline
10.4. Key benefits for the stakeholders
10.5. Research Methodology
10.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES